Cargando…

Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer

BACKGROUND: The use of PET/MRI for gynecological cancers is emerging. The purpose of this study was to assess the additional diagnostic value of PET over MRI alone in local and whole-body staging of cervical cancer, and to evaluate the benefit of standardized uptake value (SUV) and apparent diffusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner, Aida, Narva, Sara, Rinta-Kiikka, Irina, Hietanen, Sakari, Hynninen, Johanna, Virtanen, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821517/
https://www.ncbi.nlm.nih.gov/pubmed/33482909
http://dx.doi.org/10.1186/s40644-020-00372-5
_version_ 1783639438887223296
author Steiner, Aida
Narva, Sara
Rinta-Kiikka, Irina
Hietanen, Sakari
Hynninen, Johanna
Virtanen, Johanna
author_facet Steiner, Aida
Narva, Sara
Rinta-Kiikka, Irina
Hietanen, Sakari
Hynninen, Johanna
Virtanen, Johanna
author_sort Steiner, Aida
collection PubMed
description BACKGROUND: The use of PET/MRI for gynecological cancers is emerging. The purpose of this study was to assess the additional diagnostic value of PET over MRI alone in local and whole-body staging of cervical cancer, and to evaluate the benefit of standardized uptake value (SUV) and apparent diffusion coefficient (ADC) in staging. METHODS: Patients with histopathologically-proven cervical cancer and whole-body (18)F-FDG PET/MRI obtained before definitive treatment were retrospectively registered. Local tumor spread, nodal involvement, and distant metastases were evaluated using PET/MRI or MRI dataset alone. Histopathology or clinical consensus with follow-up imaging were used as reference standard. Tumor SUVmax and ADC were measured and SUVmax/ADC ratio calculated. Area under the curve (AUC) was determined to predict diagnostic performance and Mann-Whitney U test was applied for group comparisons. RESULTS: In total, 33 patients who underwent surgery (n = 23) or first-line chemoradiation (n = 10) were included. PET/MRI resulted in higher AUC compared with MRI alone in detecting parametrial (0.89 versus 0.73), vaginal (0.85 versus 0.74), and deep cervical stromal invasion (0.96 versus 0.74), respectively. PET/MRI had higher diagnostic confidence than MRI in identifying patients with radical cone biopsy and no residual at hysterectomy (sensitivity 89% versus 44%). PET/MRI and MRI showed equal AUC for pelvic nodal staging (both 0.73), whereas AUC for distant metastases was higher using PET/MRI (0.80 versus 0.67). Tumor SUVmax/ADC ratio, but not SUVmax or ADC alone, was significantly higher in the presence of metastatic pelvic lymph nodes (P < 0.05). CONCLUSIONS: PET/MRI shows higher accuracy than MRI alone for determining local tumor spread and distant metastasis emphasizing the added value of PET over MRI alone in staging of cervical cancer. Tumor SUVmax/ADC ratio may predict pelvic nodal involvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40644-020-00372-5.
format Online
Article
Text
id pubmed-7821517
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78215172021-01-22 Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer Steiner, Aida Narva, Sara Rinta-Kiikka, Irina Hietanen, Sakari Hynninen, Johanna Virtanen, Johanna Cancer Imaging Research Article BACKGROUND: The use of PET/MRI for gynecological cancers is emerging. The purpose of this study was to assess the additional diagnostic value of PET over MRI alone in local and whole-body staging of cervical cancer, and to evaluate the benefit of standardized uptake value (SUV) and apparent diffusion coefficient (ADC) in staging. METHODS: Patients with histopathologically-proven cervical cancer and whole-body (18)F-FDG PET/MRI obtained before definitive treatment were retrospectively registered. Local tumor spread, nodal involvement, and distant metastases were evaluated using PET/MRI or MRI dataset alone. Histopathology or clinical consensus with follow-up imaging were used as reference standard. Tumor SUVmax and ADC were measured and SUVmax/ADC ratio calculated. Area under the curve (AUC) was determined to predict diagnostic performance and Mann-Whitney U test was applied for group comparisons. RESULTS: In total, 33 patients who underwent surgery (n = 23) or first-line chemoradiation (n = 10) were included. PET/MRI resulted in higher AUC compared with MRI alone in detecting parametrial (0.89 versus 0.73), vaginal (0.85 versus 0.74), and deep cervical stromal invasion (0.96 versus 0.74), respectively. PET/MRI had higher diagnostic confidence than MRI in identifying patients with radical cone biopsy and no residual at hysterectomy (sensitivity 89% versus 44%). PET/MRI and MRI showed equal AUC for pelvic nodal staging (both 0.73), whereas AUC for distant metastases was higher using PET/MRI (0.80 versus 0.67). Tumor SUVmax/ADC ratio, but not SUVmax or ADC alone, was significantly higher in the presence of metastatic pelvic lymph nodes (P < 0.05). CONCLUSIONS: PET/MRI shows higher accuracy than MRI alone for determining local tumor spread and distant metastasis emphasizing the added value of PET over MRI alone in staging of cervical cancer. Tumor SUVmax/ADC ratio may predict pelvic nodal involvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40644-020-00372-5. BioMed Central 2021-01-22 /pmc/articles/PMC7821517/ /pubmed/33482909 http://dx.doi.org/10.1186/s40644-020-00372-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Steiner, Aida
Narva, Sara
Rinta-Kiikka, Irina
Hietanen, Sakari
Hynninen, Johanna
Virtanen, Johanna
Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
title Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
title_full Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
title_fullStr Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
title_full_unstemmed Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
title_short Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
title_sort diagnostic efficiency of whole-body (18)f-fdg pet/mri, mri alone, and suv and adc values in staging of primary uterine cervical cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821517/
https://www.ncbi.nlm.nih.gov/pubmed/33482909
http://dx.doi.org/10.1186/s40644-020-00372-5
work_keys_str_mv AT steineraida diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer
AT narvasara diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer
AT rintakiikkairina diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer
AT hietanensakari diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer
AT hynninenjohanna diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer
AT virtanenjohanna diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer